Hemostasis Of Artery|OMICS International|Journal Of Vascular Medicine And Surgery

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hemostasis Of Artery

Recently, many peripheral artery diseases are performed via peripheral artery. After procedure, hemostasis of artery is performed by applying local pressure either manually for femoral artery or by mechanical devices for brachial artery. However, vascular complications requiring surgical repairing may be seen in 1 to 5% of patients undergoing interventional procedures. The HemConTM pad (HemConTM Medical Technologies, Inc., Portland, OR, USA) is used armies to control traumatic bleeding in many countries. It consists of carbohydrate called chitosan produced by deacetylation of chitin, which is extracted from crustaceans. The positive charged chitosan attract the negative charged blood cells and platelets, therefore promoting hemostasis We describe here our experiences to evaluate the performance of HemConTM pad device for hemostasis after percutaneous transluminal angioplasty for peripheral artery disease. Many peripheral artery patients around the world undergo peripheral angiography and angioplasty procedure performed via peripheral artery. In order to improve in the devices for catheter procedure, the number of vascular complication has occurred. Vascular complications requiring surgery may be occurred in 1 to 5% of patients undergoing catheter procedure. Many alternative procedures exist for hemostasis following a percutaneous procedure. The most common technique is manual pressure applied to the puncture site. Furthermore, a pressure bandage is applied once hemostasis has been achieved. In the last decade, Angio-SealTM hemostatic puncture closure device is intended for use in sealing the defect in the puncture site wall produced by percutaneous access. The use of this closure device significantly improves patients’ and physicians’ comfort, however, this device also have been reported to increase thrombosis complications. Recently, chitosan -a polymer of poly-d-glucosamine and polyn- acetyl-d-glucosamine found in the crustaceans have been shown effective in promoting hemostasis. The chitosan positive charged molecules attract the negatively charged blood cells and platelets thus promoting clotting. The HemComTM pad is composed of chitosan. In battle-field, military personnel have used this pad to successfully stop arterial hemorrhage, eHemConTM pad may shortens the time to hemostasis compared to conventional manual compression in patients undergoing puncture for peripheral artery. We suggest that the compression time with 4 to 6Fr sheath and HemConTM pad is ACT×2 seconds after sheath removal. The use of the new hemostasis pad improves patients’ comfort and physicians’ stress. OMICS Group International is one of the leading Open Access Publishing houses, which has around 700+ peer-reviewed journals, 50,000+ editorial board members, and highly qualified, expert reviewers to meet the objectives of the Peer-Review Process. OMICS Group International peer-review policies are highly appreciated, accepted and adaptable to the criteria that have been prescribed by the international agencies such as NIH, PubMed etc. OMICS Group International also organizes 3000+ International Scientific Conferences per year globally.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on May, 2021